Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Entera’s proprietary N-Tab™ platform consistently delivered across our oral GLP-2 tablet, oral GLP-1/Glucagon tablet and confidential ... especially, oral anabolic therapy. Osteoporosis is one of the ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

Nonetheless, things aren't anywhere near as bad as they might seem at the moment. And Eli Lilly's cloud also has a pair of ...

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, ...

Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.

Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to $3 ...

Pendulum Therapeutics latest innovation comes in the form of a GLP-1 probiotic, acting as an appetite suppressor and healthy ...

As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased ...